1-4 of 4
David Westerman, MBBS
Close
Sort by
Journal Articles

Prolonged Progression Free Survival Does Not Relate to Quality of Response to Treatment with Thalidomide in Patients with Relapsed Multiple Myeloma (MM).

Hang Quach, MBBS, Miles H. Prince, MD MRACMA FRACPFRCPA, Linda Mileshkin, MBBS, John F. Seymour, MBBS, FRACP, PhD, David Westerman, MBBS, FRACP, FRCPA, Alvin D. Milner, PhD
Journal: Blood
Blood (2007) 110 (11): 2718.
https://doi.org/10.1182/blood.V110.11.2718.2718
Published: 2007
Journal Articles

High-Dose Dexamethasone Reduces Bortezomib-Induced Thrombocytopenia.

Hang Quach, MBBS, Miles H. Prince, MD MRACMA FRACPFRCPA, Dirk Honemann, MBBS, David Westerman, MBBS FRACP FRCPA, Alvin D. Milner, PhD, Austin Barron, BSci, Simon Harrison, MBBS
Journal: Blood
Blood (2007) 110 (11): 4820.
https://doi.org/10.1182/blood.V110.11.4820.4820
Published: 2007
Journal Articles

Safety and Efficacy of the Combination of Bortezomib with the Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma: Preliminary Results of a Phase I Trial.

Miles Prince, MBBS, Hang Quach, MBBS, Paul Neeson, MBBS, Mitch Keegan, Michael Copeman, MBBS, Stefan Peinert, MBBS, Mark Bishton, MBBS, Max Wolf, MBBS, David Ritchie, MBBS, John F. Seymour, MBBS, Dennis Carney, MBBS, David Westerman, MBBS, Simon Harrison, MBBS
Journal: Blood
Blood (2007) 110 (11): 1167.
https://doi.org/10.1182/blood.V110.11.1167.1167
Published: 2007
Journal Articles

Pax-5 Demonstrates Residual B-Cells in Bone Marrow Trephines Post Anti-CD20 Immunotherapy.

Alwyn D’Souza, MB, ChB, FRACP, Surender Juneja, MBBS, MD, FRCPA, Melanie Trivett, Dennis Carney, MBBS, FRACP, FRCPA, David Westerman, MBBS, FRACP, FRCPA
Journal: Blood
Blood (2005) 106 (11): 5013.
https://doi.org/10.1182/blood.V106.11.5013.5013
Published: 2005